Replies to post #298007 on Amarin Corp Plc (AMRN)

[Cardiologymd]

Yup. That’s why we are screwed

[ziploc_1]

HDK...no one would expect the Generics to come out and say they intend to infringe on the R-IT patents, but they came pretty close to that, when in a sales lecture to a group...they stated that the Amarin prediction for Vascepa Rx's for over 700 million Rx's per year was an indicator of what the Generics also expected to be doing.

[larry8]

So what happens if the insurance company requires the generic be used for the RI indication, is the insurance company infringing? Thanks for your help.

[larry8]

So what happens if the insurance company requires the generic be used for the RI indication, is the insurance company infringing? Thanks for your help.

[Biobillionair]

I believe the labeling is improper. It references a negative cardiovascular connection between very high Trigs yet we all know the off label for this is R-I.

To add injury to insult...TEVA is now approved!
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209525